Bipar Sciences
A pharmacological company that develops PARP inhibitors as cancer therapies
3
Funding Rounds
$68.0m
Money raised
Overview
A pharmacological company that develops PARP inhibitors as cancer therapies
- Website:
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Bipar Sciences has raised a total of $68m in funding over 3 rounds.
Key Insights:
- Bipar Sciences Series C round: $20m
- Bipar Sciences Series B round: $35m
- Bipar Sciences Series A round: $13m
Bipar Sciences Series C round
$20m
Bipar Sciences Series B round
$35m
Bipar Sciences Series A round
$13m
Industries
Bipar Sciences is active in the following industries: